Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Venous and arterial thrombosis in patients with VEXAS syndrome

Blood (2024) 143 (21): 2190–2200.

https://doi.org/10.1182/blood.2023022329

Published: 2024

Includes: Supplemental data

Journal Articles

Spectrum of clonal hematopoiesis in VEXAS syndrome

Blood (2023) 142 (3): 244–259.

https://doi.org/10.1182/blood.2022018774

Published: 2023

Includes: Supplemental data

Journal Articles

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype

Blood (2023) 141 (9): 1087–1091.

https://doi.org/10.1182/blood.2022018236

Published: 2023

Includes: Supplemental data

Journal Articles

Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformation

Blood (2022) 139 (7): 1066–1079.

https://doi.org/10.1182/blood.2021012519

Published: 2022

Includes: Supplemental data

Journal Articles

Rasburicase and Glucose 6-Phophaste Dehydrogenase: Clinical Utility in the Management of Acute Leukemia Related Hyperuricemia

Walid Mohamedali, MD, Jesus Vera Aguilera, MD, Ryan M. Carr, MD, PhD, Mythri Mudireddy, MBBS, Abhishek Mangaonkar, MD, Jonas Paludo, MD, Kebede H. Begna, MD

Blood (2017) 130 (Supplement 1): 5668.

https://doi.org/10.1182/blood.V130.Suppl_1.5668.5668

Published: 2017

Journal Articles

Prognostic Impact of ASXL1 Mutations and Extent of Bone Marrow Dysplasia in Patients with Who - defined Myelodysplastic Syndrome with Ring Sideroblasts

Abhishek Mangaonkar, MD, Terra L. Lasho, PhD, Christy Finke, BS, Naseema Gangat, MBBS, Aref Al-Kali, MD, Michelle A. Elliott, MD, Kebede H. Begna, MD, Hassan Alkhateeb, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Alexandra Wolanskyj, MD, William J. Hogan, MBBCh, Animesh Pardanani, MBBS PhD, Mark R. Litzow, MD, Ayalew Tefferi, MD, Mrinal M. Patnaik, MDMBBS

Blood (2017) 130 (Supplement 1): 2971.

https://doi.org/10.1182/blood.V130.Suppl_1.2971.2971

Published: 2017

Journal Articles

Cytokine Receptor-like Factor 2 (CRLF2) Overexpression in Myeloid Malignancies Secondary to Multiple Isodicentric Y Chromosomes: A Novel Cytogenetic Entity?

Abhishek Mangaonkar, MD, Mrinal M. Patnaik, MDMBBS, Kathleen Kaiser-Rogers, Kathleen Waldron Rao, PhD, Kevin Halling, MD PhD, Gavin Oliver, Michelle A. Elliott, MD, Patricia Greipp, DO, Daniel L. Van Dyke, PhD

Blood (2017) 130 (Supplement 1): 1702.

https://doi.org/10.1182/blood.V130.Suppl_1.1702.1702

Published: 2017

Journal Articles

Day 30 Platelet Count As a Prognostic Marker of Survival in Acute Myeloid Leukemia

Abhishek Mangaonkar, MBBS, Jamal Mohsin, Joshua Mansour, MD, Ashis Mondal, Ravindra B. Kolhe, MD PhD, Anand Jillella, MD, Vamsi Kota, M.B;B.S, Haarika Puttagunta

Blood (2014) 124 (21): 3684.

https://doi.org/10.1182/blood.V124.21.3684.3684

Published: 2014

Journal Articles

Plasma Biomarkers of Iron Regulation, Overload, and Inflammation in Sickle Cell Disease

Abhishek Mangaonkar, MBBS, Niren Patel, MBBS, Hongyan Xu, PhD, Kavita Natrajan, MBBS, Betsy Clair, Leigh G Wells, MSN, RN, FNP-BC, Latanya Bowman, RN, Nadine Barret, MSN, RN, FNP-BC, Abdullah Kutlar, MD

Blood (2014) 124 (21): 1380.

https://doi.org/10.1182/blood.V124.21.1380.1380

Published: 2014

Journal Articles

Utility Of D-Dimer As a Marker For Differentiation Syndrome and Infections In Acute Promyelocytic Leukemia (APL)

Joshua Mansour, MD, Abhishek Mangaonkar, Yousef Zakharia, MD, Arati Rani Chand, MBBS, Anand Jillella, MD, Vamsi Kota, M.B;B.S

Blood (2013) 122 (21): 4986.

https://doi.org/10.1182/blood.V122.21.4986.4986

Published: 2013

Journal Articles

Occurrence Of Deep Vein Thrombosis and Pulmonary Embolism In Acute Promyelocytic Leukemia (APL) Patients

Jennifer A. Lamneck, DO, Jeremy C. Wells, MD, Abhishek Mangaonkar, MBBS, Anand Jillella, MD, Vamsi Kota, M.B;B.S

Blood (2013) 122 (21): 5003.

https://doi.org/10.1182/blood.V122.21.5003.5003

Published: 2013

Journal Articles

Utility and Impact Of Early t(15;17) Identification By Fluorescence In Situ Hybridization (FISH) In Clinical Decision Making For Patients With Acute Promyelocytic Leukemia (APL)

Abhishek Mangaonkar, M.B;B.S, Vamsi Kota, M.B;B.S, Amyn Rojiani, MD, Anand Jillella, MD, Ravindra B. Kolhe, MD, PhD

Blood (2013) 122 (21): 4968.

https://doi.org/10.1182/blood.V122.21.4968.4968

Published: 2013

NARROW

Venous and arterial thrombosis in patients with VEXAS syndrome

Spectrum of clonal hematopoiesis in VEXAS syndrome

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype

Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformation

Rasburicase and Glucose 6-Phophaste Dehydrogenase: Clinical Utility in the Management of Acute Leukemia Related Hyperuricemia

Prognostic Impact of ASXL1 Mutations and Extent of Bone Marrow Dysplasia in Patients with Who - defined Myelodysplastic Syndrome with Ring Sideroblasts

Cytokine Receptor-like Factor 2 (CRLF2) Overexpression in Myeloid Malignancies Secondary to Multiple Isodicentric Y Chromosomes: A Novel Cytogenetic Entity?

Day 30 Platelet Count As a Prognostic Marker of Survival in Acute Myeloid Leukemia

Plasma Biomarkers of Iron Regulation, Overload, and Inflammation in Sickle Cell Disease

Utility Of D-Dimer As a Marker For Differentiation Syndrome and Infections In Acute Promyelocytic Leukemia (APL)

Occurrence Of Deep Vein Thrombosis and Pulmonary Embolism In Acute Promyelocytic Leukemia (APL) Patients

Utility and Impact Of Early t(15;17) Identification By Fluorescence In Situ Hybridization (FISH) In Clinical Decision Making For Patients With Acute Promyelocytic Leukemia (APL)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only